Keywords = Bladder cancer
| Number of Articles: 40 | ||||
| 1 | Evaluation of functional outcomes of Studer ileal orthotopic bladder substitutions | |||
| Articles in Press, Accepted Manuscript , Available Online from 05 February 2024 | ||||
| mohamed gamal; Mohamed Hamdy Aboelhassan; Mamdouh Abdel hamid Abdel raheum; tarek osman el-sayed; Ahmed Hakim Abdelgawad | ||||
| 2 | Urinary microbiota and lower urinary tract disorders | |||
| Articles in Press, Corrected Proof , Available Online from 20 December 2023 | ||||
| Alshimaa Moawad Abdelrhman Elahwal; Sherif Moussa Husseiny; Ahmed Abdulaziz Sayed; Amira Awadalla Mohamed | ||||
| 3 | Evaluation of Minichromosome Maintenance Deficient-5 Levels in non-Muscle invasive Bladder Cancer Patients | |||
| Volume 67, Issue 7, July 2024, Page 581-588 | ||||
| Faten Zahran Mohamed; Reda Abdelaal; Ehab Elbadry; Waleed Mohamed Serag | ||||
| 4 | Changes in histopathological phenotypes of Schistosomaassociated urinary bladder cancer in Sohag, Egypt | |||
| Volume 17, Issue 1, April 2024, Page 24-28 | ||||
| Asmaa Abd Ellah; Maisa Mohammed | ||||
| 5 | ERCC1 rs11615 Single Nucleotide Polymorphism in Bladder Cancer Patients and Safety Outcomes of Cisplatin-Based Chemotherapy | |||
| Volume 5, Issue 1, March 2024, Page 42-48 | ||||
| Khaled M Kotb; Moetaza M Soliman; Amira Awadallah; Asmaa E Ahmed; Hassan Abol-Enein; Mohamed E E Shams | ||||
| 6 | Management of Muscle Invasive Bladder Cancer with Weekly Gemcitabine Concurrent with Radiotherapy Post-Transurethral Tumor Resection in Old Fragile Patients: our Institute Experience | |||
| Volume 30, Issue 1, January and February 2024, Page 120-130 | ||||
| OLA Elfarargy; Reham Salem; Ahmed A. Obaya; Mostafa Kamel; Maged Mohammed Ali; Nora Atef; DALIA HAMOUDA ELSAYED | ||||
| 7 | Clinico-Epidemiological Study on Neoadjuvant Chemotherapy Followed by Chemoradiotherapy in Muscle-Invasive Bladder Cancer at Assiut University Hospital | |||
| Volume 9, Issue 1, January 2024, Page 7-14 | ||||
| Abeer Amin; Hoda Essa; Rehab Abd-Elmaboud; Samar El-Morshedy | ||||
| 8 | Molecular Evaluation of BH3-mimics Inhibitor of Bladder Cancer as Targiting Chemotherapy(Review article) | |||
| Volume 5, Issue 1, January 2024, Page 45-62 | ||||
| Eman Ibrahim Elmoghazy; Mahmoud zakaria; Ali Hussein Abu Almaaty; Mohamed Kamel Hassan | ||||
| 9 | Urinary microbiota and lower urinary tract disorders | |||
| Volume 40, Issue 2, 2023, Page 26-52 | ||||
| Alshimaa Moawad Abdelrhman Elahwal; SH. M. Husseiny; A. sayed Ahmed; Amira Awadalla | ||||
| 10 | The high prevalence of muscle invasive disease among bladder cancer patients attending a regional hospital in Durban, South Africa | |||
| Volume 6, Issue 2, July 2023, Page 68-80 | ||||
| Siphesihle Mbatha; Vishan Mohanlal Ramloutan; Colleen Aldous | ||||
| 11 | Evaluation of Patients' Knowledge about Bladder Cancer | |||
| Volume 10, Issue 2, July 2023, Page 95-102 | ||||
| Hanan Farag; Wafaa Sherif; Ahmed EL-Hefnawy; Hanan Mohamed | ||||
| 12 | Effect of Designed Nursing Protocol on Self-Reported Outcomes among Patients with Bladder Cancer Undergoing Radical Cystectomy | |||
| Volume 4, Issue 2, July 2023, Page 926-952 | ||||
| Mohamed Gamal Ibrahim Alshaar; Marwa Mossad Ali; Hend Mohamed Allam | ||||
| 13 | Clinico-pathological Features of Squamous Cell Carcinoma of Urinary Bladder at South Egypt Cancer Institute (Retrospective Study) | |||
| Volume 11, Issue 3, July 2023, Page 236-243 | ||||
| 14 | Diagnostic Value of Diffusion-Weighted MR Imaging in Differentiating T- Stage of Urinary Bladder Cancer: With Histopathological Correlation | |||
| Volume 8, Issue 6, June 2023, Page 69-74 | ||||
| Haitham Ibraheem; Khaled Lakouz; Mohamed Hosny | ||||
| 15 | Prognostic role of CHEK2, FASN and Her2/neu Expression in Stage Ta-T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) | |||
| Volume 91, Issue 1, April 2023, Page 5266-5275 | ||||
| Noha F. Elaidy; Abeer M. Abdelbary; Ebtisam R. Qasem; Ahmed M Eliwa; Hanaa M. Ibrahim | ||||
| 16 | ASSESSMENT OF SET-UP ERROR IN THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY (3-DCRT) DURING THE TREATMENT OF PATIENTS WITH PROSTATE OR BLADDER CANCERS IN AYADI EL-MOSTAKBAL HOSPITAL (ALEXANDRIA, EGYPT) | |||
| Volume 73, Issue 4, December 2022, Page 901-917 | ||||
| El Naggar M; Alrwie M; Al-Zayat D; El-Abd E; Abou El-Eneen M | ||||
| 17 | The Level of Survivin in The Blood and Urine Samples of Bladder Cancer Patients Using the ELISA Method | |||
| Volume 89, Issue 2, October 2022, Page 8065-8069 | ||||
| Aesha S. Ali; Mohammed R. Ali; Sadeq K. Hachim | ||||
| 18 | Clinicoepidemiological Study of Locally Advanced Bladder Cancer: single institution experience. | |||
| Volume 6, Issue 3, September 2022, Page 1-10 | ||||
| Shimaa Elmetwaly Attia; Soumaya Eteba; Wafaa El-Beshbishi; Mohammed Shabara | ||||
| 19 | Significance of HER2 expression in urinary bladder cancer: single institutional data | |||
| Volume 10, Issue 3, July 2022, Page 136-145 | ||||
| 20 | Hormonal receptors expression in urinary bladder cancer | |||
| Volume 10, Issue 2, May 2022, Page 108-115 | ||||
| 21 | Value of Low Dose Short Hypofractionated Palliative Radiation Therapy in the Management of Bladder Cancer | |||
| Volume 87, Issue 1, April 2022, Page 1241-1247 | ||||
| Sara F. Mahmoud; Mohammad A. Mazrouh; Mostafa M. Toam; Heba M. Abd-Elhamed | ||||
| 22 | Epidemiological and Clinico-Pathological Characteristics of Bladder Cancer at Clinical Oncology Department, Zagazig University: Retrospective Analysis | |||
| Volume 85, Issue 1, October 2021, Page 3251-3255 | ||||
| Osama Abdel Fattah; Yousra Dorgham; Mohammed Abdelgawad; Ibrahim Nasr | ||||
| 23 | Impact of SOX2 and CD44 as Cancer Stem Cell Markers in Urinary Bladder Carcinoma | |||
| Volume 5, Issue 3, September 2021, Page 27-34 | ||||
| Basma Amer; Alaa Amer | ||||
| 24 | Role of Urine Cytology in Accurate Diagnosis of Urothelial Carcinoma: An Immunohistochemical Study | |||
| Volume 27, Issue 4, July 2021, Page 664-671 | ||||
| Yousef Baumy; Masoud Omar; Raafat Hegazy; Naglaa Ramadan; Hamdy Desouky | ||||
| 25 | Tumour-associated macrophages (IL-23+CD14+ subset) levels during bladder cancer progression | |||
| Volume 2, Issue 1, 2021, Page 11-18 | ||||
| Mohammed Saad El-Gedamy; Dr. Hassan Abolenein; Zakaria Elkhayat; Afaf Elsaid; Islam M Elnahrery | ||||
| | ||||
View on SCiNiTO
